Dysautonomia, but Not Cardiac Dysfunction, Is Common in a Cohort of Individuals with Long COVID
- PMID: 38003921
- PMCID: PMC10671897
- DOI: 10.3390/jpm13111606
Dysautonomia, but Not Cardiac Dysfunction, Is Common in a Cohort of Individuals with Long COVID
Abstract
Despite the prevalence of dysautonomia in people with Long COVID, it is currently unknown whether Long COVID dysautonomia is routinely accompanied by structural or functional cardiac alterations. In this retrospective observational study, the presence of echocardiographic abnormalities was assessed. Left ventricular (LV) chamber sizes were correlated to diagnostic categories and symptoms via standardized patient-reported outcome (PRO) questionnaires. A total of 203 individuals with Long COVID without pre-existing cardiac disease and with available echocardiograms were included (mean age, 45 years; 67% female). Overall, symptoms and PRO scores for fatigue, breathlessness, quality of life, disability, anxiety and depression were not different between those classified with post-COVID dysautonomia (PCD, 22%) and those unclassified (78%). An LV internal diameter at an end-diastole z score < -2 was observed in 33 (16.5%) individuals, and stroke volume (SV) was lower in the PCD vs. unclassified subgroup (51.6 vs. 59.2 mL, 95% C.I. 47.1-56.1 vs. 56.2-62.3). LV end-diastolic volume (mean diff. (95% CI) -13 [-1--26] mL, p = 0.04) and SV (-10 [-1--20] mL, p = 0.03) were smaller in those individuals reporting a reduction in physical activity post-COVID-19 infection, and smaller LVMI was weakly correlated with worse fatigue (r = 0.23, p = 0.02). The majority of individuals with Long COVID report shared symptoms and did not demonstrate cardiac dysfunction on echocardiography.
Keywords: PASC; dysautonomia; echocardiogram; long COVID; post-acute sequelae of COVID; postural orthostatic tachycardia syndrome (POTS).
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Long COVID-19 and Postural Orthostatic Tachycardia Syndrome- Is Dysautonomia to Be Blamed?Front Cardiovasc Med. 2022 Mar 9;9:860198. doi: 10.3389/fcvm.2022.860198. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35355961 Free PMC article. Review.
-
Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19.Ann Neurol. 2022 Mar;91(3):367-379. doi: 10.1002/ana.26286. Epub 2022 Jan 18. Ann Neurol. 2022. PMID: 34952975 Free PMC article.
-
Post-acute sequelae of SARS-CoV-2 syndrome presenting as postural orthostatic tachycardia syndrome.Clin Exp Emerg Med. 2023 Mar;10(1):18-25. doi: 10.15441/ceem.22.409. Epub 2023 Jan 30. Clin Exp Emerg Med. 2023. PMID: 36718484 Free PMC article.
-
Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?Front Neurol. 2024 Feb 8;15:1344862. doi: 10.3389/fneur.2024.1344862. eCollection 2024. Front Neurol. 2024. PMID: 38390594 Free PMC article. Review.
-
Dysautonomia: A Forgotten Condition - Part 1.Arq Bras Cardiol. 2021 Apr;116(4):814-835. doi: 10.36660/abc.20200420. Arq Bras Cardiol. 2021. PMID: 33886735 Free PMC article. English, Portuguese.
Cited by
-
A deeper look at long-term effects of COVID-19 on myocardial function in survivors with no prior heart diseases: a GRADE approach systematic review and meta-analysis.Front Cardiovasc Med. 2024 Nov 19;11:1458389. doi: 10.3389/fcvm.2024.1458389. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39628552 Free PMC article.
References
-
- Lala A., Johnson K.W., Januzzi J.L., Russak A.J., Paranjpe I., Richter F., Zhao S., Somani S., Van Vleck T., Vaid A., et al. Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection. J. Am. Coll Cardiol. 2020;76:533–546. doi: 10.1016/j.jacc.2020.06.007. - DOI - PMC - PubMed
-
- Nakatani S., Ohta-Ogo K., Nishio M., Amemiya K., Sato S., Sawano H., Hatakeyama K., Katano H., Suzuki T., Hirooka K. Microthrombosis as a cause of fulminant myocarditis-like presentation with COVID-19 proven by endomyocardial biopsy. Cardiovasc. Pathol. 2022;60:107435. doi: 10.1016/j.carpath.2022.107435. - DOI - PMC - PubMed
-
- Farkouh M.E., Stone G.W., Lala A., Bagiella E., Moreno P.R., Nadkarni G.N., Ben-Yehuda O., Granada J.F., Dressler O., Tinuoye E.O., et al. Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week. J. Am. Coll. Cardiol. 2022;79:917–928. doi: 10.1016/j.jacc.2021.12.023. - DOI - PMC - PubMed
-
- Sperotto F., Friedman K.G., Son M.B.F., VanderPluym C.J., Newburger J.W., Dionne A. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: A comprehensive review and proposed clinical approach. Eur. J. Pediatr. 2021;180:307–322. doi: 10.1007/s00431-020-03766-6. - DOI - PMC - PubMed
-
- Aldeghaither S.M., Qutob R.M., Assanangkornchai N.M., Issa-Chergui B., Tam M.C., Larotondo R., Samoukovic G.M. Clinical and Histopathologic Features of Myocarditis in Multisystem Inflammatory Syndrome (Adult)-Associated COVID-19. Crit. Care Explor. 2022;10:e0630. doi: 10.1097/CCE.0000000000000630. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources